Liu Jie-yu, Li Zhi-gang, Gao Chao, Cui Lei, Wu Min-yuan
Hematology Center, Beijing Children's Hospital Affiliated to Capital Medical University, Beijing 100045, China.
Zhonghua Er Ke Za Zhi. 2008 Jul;46(7):487-92.
To explore the characteristics of T cell receptor beta (TCRbeta) gene rearrangements in children with T-cell acute lymphoblastic leukemia (T-ALL) and establish a system of quantitative detection of MRD with real-time quantitative (RQ-PCR) targeted at TCRbeta gene rearrangement.
Multiplex polymerase chain reaction (PCR) designed by BIOMED-2 was used to detect TCRbeta gene rearrangements in the bone marrow samples of 26 children with T-ALL. Sequence of junction region were then compared and analyzed in IMGT database. Allele specific oligonucleotide (ASO) upstream primers were designed complementary to the V-D-J or D-J junctional region of TCRbeta gene rearrangements. Samples at diagnosis were serially diluted in DNA obtained from mononuclear cells (MNC) from a pool of 20 healthy donors to generate the patient specific standard curves. Subsequently, a TCRbeta RQ-PCR assay to quantify MRD with germline Jbeta primer/probe combinations was applied in six patients. To check the quantity and quality of DNA, the investigators used RQ-PCR analysis for the N-ras gene.
Clonal rearrangements were identified in 92.3% childhood T-ALL (Vbeta-Dbeta-Jbeta rearrangements in 84.6%, Dbeta-Jbeta rearrangements in 50%). Comparative sequence analysis of 42 TCRbeta recombinations revealed two downstream Vbeta families (BV5, BV6) were preferentially used. The segment Jbeta2.7 in childhood T-ALL was preferentially used. Jbeta1.3, Jbeta2.4, and Jbeta2.6 were not found to be used. The slope of the standard curves was from -3.54 to -3.37 and the intercepts were from 19.35 to 20.51. The correlation coefficients of all 6 standard curves were excellent (> or = 0.98). All the RQ-PCR quantitative range reached 10(-4). MRD analysis of follow up samples showed that MRD increased before relapse.
RQ-PCR analysis of TCRbeta gene rearrangements was highly sensitive and specific, it will be of high value for future T-ALL MRD studies. And quantitative and serial study of MRD may be of prognostic importance.
探讨T细胞急性淋巴细胞白血病(T-ALL)患儿T细胞受体β(TCRβ)基因重排的特征,并建立针对TCRβ基因重排的实时定量(RQ-PCR)微小残留病(MRD)定量检测体系。
采用BIOMED-2设计的多重聚合酶链反应(PCR)检测26例T-ALL患儿骨髓样本中的TCRβ基因重排。然后在IMGT数据库中对连接区序列进行比较和分析。设计等位基因特异性寡核苷酸(ASO)上游引物,使其与TCRβ基因重排的V-D-J或D-J连接区互补。将诊断时的样本在来自20名健康供体的单核细胞(MNC)的DNA中进行系列稀释,以生成患者特异性标准曲线。随后,应用TCRβ RQ-PCR检测法,采用种系Jβ引物/探针组合对6例患者进行MRD定量。为检测DNA的量和质量,研究人员对N-ras基因进行了RQ-PCR分析。
在92.3%的儿童T-ALL中鉴定出克隆性重排(84.6%为Vβ-Dβ-Jβ重排,50%为Dβ-Jβ重排)。对42个TCRβ重组进行的比较序列分析显示,两个下游Vβ家族(BV5和BV6)被优先使用。儿童T-ALL中优先使用Jβ2.7片段。未发现使用Jβ1.3、Jβ